Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
Robak, Tadeusz, Dmoszynska, Anna, Solal-Céligny, Philippe, Warzocha, Krzysztof, Loscertales, Javier, Catalano, John, Afanasiev, Boris V, Larratt, Loree, Geisler, Christian H, Montillo, Marco, Zyuzgin, Ilya, Ganly, Peter S, Dartigeas, Caroline, Rosta, András, Maurer, Jörg, Mendila, Myriam, Saville, M Wayne, Valente, Nancy, Wenger, Michael K, Moiseev, Sergey I
Published in Journal of clinical oncology (01.04.2010)
Published in Journal of clinical oncology (01.04.2010)
Get full text
Journal Article
Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia
KNAUF, Wolfgang U, LISSICHKOV, Toshko, BECKER, Martin, FRICKE, Hans-Joerg, HUGUET, Francoise, DEL GIUDICE, Ilaria, KLEIN, Peter, TREMMEL, Lothar, MERKLE, Karlheinz, MONTILLO, Marco, ALDAOUD, Ali, LIBERATI, Anna, LOSCERTALES, Javier, HERBRECHT, Raoul, JULIUSSON, Gunnar, POSTNER, Gerhard, GERCHEVA, Liana, GORANOV, Stefan
Published in Journal of clinical oncology (10.09.2009)
Published in Journal of clinical oncology (10.09.2009)
Get full text
Journal Article
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody
Mateu-Albero, Tamara, Juárez-Sánchez, Raquel, Loscertales, Javier, Mol, Wim, Terrón, Fernando, Muñoz-Calleja, Cecilia, Cuesta-Mateos, Carlos
Published in Cancer Immunology, Immunotherapy (01.03.2022)
Published in Cancer Immunology, Immunotherapy (01.03.2022)
Get full text
Journal Article
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
Jones, Jeffrey A, Robak, Tadeusz, Brown, Jennifer R, Awan, Farrukh T, Badoux, Xavier, Coutre, Steven, Loscertales, Javier, Taylor, Kerry, Vandenberghe, Elisabeth, Wach, Malgorzata, Wagner-Johnston, Nina, Ysebaert, Loic, Dreiling, Lyndah, Dubowy, Ronald, Xing, Guan, Flinn, Ian W, Owen, Carolyn
Published in The Lancet. Haematology (01.03.2017)
Published in The Lancet. Haematology (01.03.2017)
Get more information
Journal Article
Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial
Robak, Tadeusz, Warzocha, Krzysztof, Govind Babu, K., Kulyaba, Yaroslav, Kuliczkowski, Kazimierz, Abdulkadyrov, Kudrat, Loscertales, Javier, Kryachok, Iryna, Kłoczko, Janusz, Rekhtman, Grygoriy, Homenda, Wojciech, Błoński, Jerzy Z., McKeown, Astrid, Gorczyca, Michele M., Carey, Jodi L., Chang, Chai-Ni, Lisby, Steen, Gupta, Ira V., Grosicki, Sebastian
Published in Leukemia & lymphoma (04.05.2017)
Published in Leukemia & lymphoma (04.05.2017)
Get full text
Journal Article
Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL
Cuesta-Mateos, Carlos, Juárez-Sánchez, Raquel, Mateu-Albero, Tamara, Loscertales, Javier, Mol, Wim, Terrón, Fernando, Muñoz-Calleja, Cecilia
Published in mAbs (01.01.2021)
Published in mAbs (01.01.2021)
Get full text
Journal Article
Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study
Loscertales, Javier, Abrisqueta-Costa, Pau, Gutierrez, Antonio, Hernández-Rivas, José Ángel, Andreu-Lapiedra, Rafael, Mora, Alba, Leiva-Farré, Carolina, López-Roda, María Dolores, Callejo-Mellén, Ángel, Álvarez-García, Esther, García-Marco, José Antonio
Published in Cancers (01.08.2023)
Published in Cancers (01.08.2023)
Get full text
Journal Article
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients
Mateu-Albero, Tamara, Marcos-Jimenez, Ana, Wissmann, Stefanie, Loscertales, Javier, Terrón, Fernando, Stein, Jens V, Muñoz-Calleja, Cecilia, Cuesta-Mateos, Carlos
Published in Cancers (31.05.2022)
Published in Cancers (31.05.2022)
Get full text
Journal Article
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
Cuesta-Mateos, Carlos, Fuentes, Patricia, Schrader, Alexandra, Juárez-Sánchez, Raquel, Loscertales, Javier, Mateu-Albero, Tamara, Vega-Piris, Lorena, Espartero-Santos, Marina, Marcos-Jimenez, Ana, Sánchez-López, Blanca Andrea, Pérez-García, Yaiza, Jungherz, Dennis, Oberbeck, Sebastian, Wahnschaffe, Linus, Kreutzman, Anna, Andersson, Emma I, Mustjoki, Satu, Faber, Edgar, Urzainqui, Ana, Fresno, Manuel, Stamatakis, Kostantino, Alfranca, Arantzazu, Terrón, Fernando, Herling, Marco, Toribio, María Luisa, Muñoz-Calleja, Cecilia
Published in Biomarker research (24.10.2020)
Published in Biomarker research (24.10.2020)
Get full text
Journal Article
Angioimmunoblastic T‐cell lymphoma after acute myeloid leukemia: Alleged common pathogenesis. A case report and literature review
Iturrate, Isabel, Loscertales, Javier, Fernández‐Ruiz, Elena, Muñoz, Patricia, López, Consuelo, del Campo, Luciana, Muñoz, Cecilia, Alegre, Adrián
Published in Clinical case reports (01.12.2020)
Published in Clinical case reports (01.12.2020)
Get full text
Journal Article
Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia
Alfonso‐Pérez, Manuel, López‐Giral, Sonia, Quintana, Nuria E., Loscertales, Javier, Martín‐Jiménez, Patricia, Muñoz, Cecilia
Published in Journal of leukocyte biology (01.06.2006)
Published in Journal of leukocyte biology (01.06.2006)
Get full text
Journal Article
Final Results From a Phase II Trial with the First in Class Recombinant Polyclonal Antibody Product Rozrolimupab in Primary Immune Thrombocytopenia
Robak, Tadeusz, Trelinski, Jacek, von Depka Prondzinski, Mario, Giagounidis, Aristoteles, Doyen, Chantal, Janssens, Ann, Román, Mayte Álvarez, Pueyo, Javier Loscertales, Ramos, Isidro Jarque, Loscertales, Javier, Rus, Gloria Pérez, Hellmann, Andrzej, Wiktor-Jedrzejczak, Wieslaw, Kuliczkowski, Kazimierz, Golubovic, Lana, Celeketic, Dusica, Cucuianu, Andrei, Gheorghita, Emanuil, Mihaela, Lazaroiu, Attias, Dina, Shpilberg, Ofer, Karyagina, Elena, Vilchevska, Kateryna, Svetlana, Kalinina, Cooper, Nichola, Talks, Kate, Prabhu, Mukyaprana, Prasad, Sripada V.S.S, Bharadwaj, T.P. Raghava, Flensburg, Mimi Folden, Petersen, Jorgen, Windyga, Jerzy
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Long-Term Follow-up of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia: A Single-Center Experience
García Herce, Cristina, Gómez García de Soria, Valle, Alonso, Alejandro, Feijóo, Samantha, García-Noblejas, Ana, Loscertales, Javier, Figuera, Angela, Steegmann, Juan Luis
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Abstract 4849: CAP-100: first-in-class anti-CCR7 antibody for CLL
Cuesta-Mateos, Carlos, Muñoz-Calleja, Cecilia, Loscertales, Javier, Terron, Fernando, Mol, Wim
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
CAP-100: First-in-class antibody for CCR7 + hematological malignancies
Cuesta, Carlos, Munoz-Callega, Cecilia, Loscertales, Javier, Terron, Fernando, Mol, Wim
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
Abrisqueta, Pau, Delgado, Julio, Alcoceba, Miguel, Oliveira, Ana Carla, Loscertales, Javier, Hernández‐Rivas, Jose A., Ferrà, Christelle, Cordoba, Raul, Yáñez, Lucrecia, Medina, Angeles, Motlló, Cristina, Iacoboni, Gloria, Villacampa, Guillermo, González, Marcos, Bosch, Francesc
Published in British journal of haematology (01.09.2020)
Published in British journal of haematology (01.09.2020)
Get full text
Journal Article
Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients
Labrador, Jorge, Cuevas, Maria Victoria, Alonso-Madrigal, Cristina, Zubiaur, Pablo, Azibeiro, Raul, Cuevas, Beatriz, Alvarez, Rodolfo, Diaz-Galvez, Francisco Javier, Gonzalez-Lopez, Tomas Jose, Alcaraz, Raquel, Mejía-Abril, Gina Paola, Loscertales, Javier, Abad, Francisco, Saiz-Rodríguez, Miriam
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study
Al-Sawaf, Othman, Robrecht, Sandra, Zhang, Can, Olivieri, Stefano, Chang, Yi Meng, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Sivcheva, Liliya, Niemann, Carsten Utoft, Schwarer, Anthony P., Loscertales, Javier, Weinkove, Robert, Strumberg, Dirk, Kilfoyle, Allanah, Manzoor, Beenish S., Jawaid, Dureshahwar, Emechebe, Nnadozie, Devine, Jacob, Boyer, Michelle, Runkel, Eva D, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael J, Fischer, Kirsten
Published in Blood (10.07.2024)
Published in Blood (10.07.2024)
Get full text
Journal Article
The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia
Al-Sawaf, Othman, Fürstenau, Moritz, Giza, Adam, Robrecht, Sandra, Von Tresckow, Julia, Fink, Anna Maria, Simon, Florian, Tausch, Eugen, Schneider, Christof, Sivcheva, Liliya, Schwarer, Anthony, Loscertales, Javier, Weinkove, Robert, Strumberg, Dirk, Kilfoyle, Allanah R., Juliusson, Gunnar, Da Cunha-Bang, Caspar, Illmer, Thomas, Gregor, Michael, Thornton, Patrick, Janssens, Ann, Tadmor, Tamar, Lindström, Vesa, Staber, Philipp Bernhard, Levin, Mark-David, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Ritgen, Matthias, Stilgenbauer, Stephan, Kater, Arnon P., Niemann, Carsten Utoft, Fischer, Kirsten, Eichhorst, Barbara F., Hallek, Michael
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela, Cramer, Paula
Published in Leukemia & lymphoma (09.11.2020)
Published in Leukemia & lymphoma (09.11.2020)
Get full text
Journal Article